Intrinsic Value of S&P & Nasdaq Contact Us

ICON Public Limited Company ICLR NASDAQ

NASDAQ Global Select • Healthcare • Medical - Diagnostics & Research • IE • USD

SharesGrow Score
71/100
4/7 Pass
SharesGrow Intrinsic Value
$217.20
+92.1%
Analyst Price Target
$157.44
+39.3%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

ICON Public Limited Company (ICLR) has shown strong revenue growth over the past 3 years, expanding from $5.5B to $8.3B (average +16%/yr). Net income reached $791M, reflecting exceptional earnings expansion at +93.4%/yr on average. The net profit margin is 9.6%, which is moderate. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 29.4% (low), with a +1.9pp trend over the period. With a $9B market cap and MOAT composite score of 49/100, the company has a moderate competitive position.

Criteria proven by this page:

  • GROWTH (90/100, Pass) — proving strong growth momentum
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 28-year history, the company was profitable in 27 of 28 years — an excellent long-term track record
  • INCOME (45/100, Partial) — the company is profitable but margin is below 15%
  • MOAT (49/100, Partial) — some competitive advantages are present but not dominant

Overall SharesGrow Score: 71/100 with 4/7 criteria passed.

71/100
SG Score
View full scorecard →
VALUE
80/100
Price-to-Earnings & upside
→ IV page
FUTURE
64/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 yrs profit
EPS $9.53
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
49/100
Score: 49/100
GM 29.4% (+1.9pp)
Proven by this page
GROWTH
90/100
Rev +16%/yr
NI +93.4%/yr
Proven by this page
~
INCOME
45/100
Margin 9.6%
$8.3B
Proven by this page
ICON Public Limited Company Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2024 FY2023 FY2022 FY2021
Revenue $8.1B$8.28B$8.12B$7.74B$5.48B
Gross Profit $2.18B$2.44B$2.4B$2.21B$1.51B
Gross Margin 26.9%29.4%29.6%28.6%27.5%
Operating Income $984.7M$1.1B$956.15M$795.24M$608.47M
Net Income $599.48M$791.47M$612.34M$505.3M$153.19M
Net Margin 7.4%9.6%7.5%6.5%2.8%
EPS (Diluted) $7.36$9.53$7.40$6.13$2.25
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message